GB201019118D0 - Conjugates and their uses in molecular imaging - Google Patents

Conjugates and their uses in molecular imaging

Info

Publication number
GB201019118D0
GB201019118D0 GB201019118A GB201019118A GB201019118D0 GB 201019118 D0 GB201019118 D0 GB 201019118D0 GB 201019118 A GB201019118 A GB 201019118A GB 201019118 A GB201019118 A GB 201019118A GB 201019118 D0 GB201019118 D0 GB 201019118D0
Authority
GB
United Kingdom
Prior art keywords
conjugates
molecular imaging
imaging
molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201019118A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
KING'S COLLEGE
Original Assignee
Kings College London
KING'S COLLEGE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London, KING'S COLLEGE filed Critical Kings College London
Priority to GB201019118A priority Critical patent/GB201019118D0/en
Publication of GB201019118D0 publication Critical patent/GB201019118D0/en
Priority to PCT/GB2011/001599 priority patent/WO2012063028A1/en
Priority to EP11788554.1A priority patent/EP2637705B1/en
Priority to ES11788554.1T priority patent/ES2625829T3/es
Priority to AU2011327931A priority patent/AU2011327931B2/en
Priority to US13/884,660 priority patent/US9138495B2/en
Priority to JP2013538264A priority patent/JP5986095B2/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A61K51/1033—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants against receptors for cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB201019118A 2010-11-11 2010-11-11 Conjugates and their uses in molecular imaging Ceased GB201019118D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB201019118A GB201019118D0 (en) 2010-11-11 2010-11-11 Conjugates and their uses in molecular imaging
PCT/GB2011/001599 WO2012063028A1 (en) 2010-11-11 2011-11-11 Conjugates and their uses in molecular imaging
EP11788554.1A EP2637705B1 (en) 2010-11-11 2011-11-11 Conjugates and their uses in molecular imaging
ES11788554.1T ES2625829T3 (es) 2010-11-11 2011-11-11 Conjugados y sus usos en la obtención de imágenes moleculares
AU2011327931A AU2011327931B2 (en) 2010-11-11 2011-11-11 Conjugates and their uses in molecular imaging
US13/884,660 US9138495B2 (en) 2010-11-11 2011-11-11 Conjugates and their uses in molecular imaging
JP2013538264A JP5986095B2 (ja) 2010-11-11 2011-11-11 コンジュゲートおよび分子イメージングにおけるそれらの用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201019118A GB201019118D0 (en) 2010-11-11 2010-11-11 Conjugates and their uses in molecular imaging

Publications (1)

Publication Number Publication Date
GB201019118D0 true GB201019118D0 (en) 2010-12-29

Family

ID=43431334

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201019118A Ceased GB201019118D0 (en) 2010-11-11 2010-11-11 Conjugates and their uses in molecular imaging

Country Status (7)

Country Link
US (1) US9138495B2 (enExample)
EP (1) EP2637705B1 (enExample)
JP (1) JP5986095B2 (enExample)
AU (1) AU2011327931B2 (enExample)
ES (1) ES2625829T3 (enExample)
GB (1) GB201019118D0 (enExample)
WO (1) WO2012063028A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7098442B2 (en) 2003-03-05 2006-08-29 Raytheon Company Thin micropolarizing filter, and a method for making it
CA2830349C (en) 2011-03-17 2019-07-16 The University Of Birmingham Re-directed immunotherapy
EP4147724A1 (en) 2013-10-31 2023-03-15 Beth Israel Deaconess Medical Center Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
US11001562B2 (en) 2013-10-31 2021-05-11 Beth Israel Deaconess Medical Center Near-infrared fluorescent nerve contrast agents and methods of use thereof
GB201417067D0 (en) 2014-09-26 2014-11-12 South African Nuclear Energy Radiopharmaceutical conjugate
GB201504064D0 (en) * 2015-03-10 2015-04-22 Accretion Biotechnology Ltd Method and kits for preparing radionuclide complexes
JP7253762B2 (ja) * 2017-12-27 2023-04-07 慈濟大學 タンパク質を表面に発現させた小胞によるオートファジー細胞およびアポトーシス細胞への薬剤送達
US20250082795A1 (en) 2023-09-12 2025-03-13 Curadel Surgical Innovations, Inc. Combinations of imaging agent conjugates and application thereof
CN120590625A (zh) * 2024-11-06 2025-09-05 江苏申命医疗科技有限公司 一种放射性核素标记的聚合物、其制备方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0672142B1 (en) 1992-12-04 2001-02-28 Medical Research Council Multivalent and multispecific binding proteins, their manufacture and use
AU2865995A (en) 1995-06-14 1997-01-15 Regents Of The University Of California, The 3-hydroxy-2(1h)-pyridinone chelating agents
WO2007042504A2 (fr) * 2005-10-07 2007-04-19 Guerbet Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
US8158804B2 (en) 2007-01-11 2012-04-17 Ge Healthcare As Chelating agents
US8475768B2 (en) 2007-08-13 2013-07-02 Ge Healthcare As Paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (MRI)
US9209965B2 (en) 2014-01-14 2015-12-08 Microsemi Semiconductor Ulc Network interface with clock recovery module on line card

Also Published As

Publication number Publication date
WO2012063028A1 (en) 2012-05-18
JP5986095B2 (ja) 2016-09-06
AU2011327931A1 (en) 2013-07-04
US9138495B2 (en) 2015-09-22
AU2011327931A2 (en) 2013-07-11
US20140056810A1 (en) 2014-02-27
EP2637705B1 (en) 2017-03-29
ES2625829T3 (es) 2017-07-20
AU2011327931B2 (en) 2017-02-23
EP2637705A1 (en) 2013-09-18
JP2014501714A (ja) 2014-01-23

Similar Documents

Publication Publication Date Title
ZA201206449B (en) Pyrrolobenzodiazepines and conjugates thereof
GB201009455D0 (en) Nanoparticles and their uses in molecular imaging
IL252398B (en) cd37-binding molecules and their immunoconjugates
SG10201801503XA (en) e-POLYLYSINE CONJUGATES AND USE THEREOF
IL231796A (en) Pyrolobenzodiazepines and their conjugates
IL222269A (en) Target-targeted pyrolobenzodiazepine couplings
EP2600760A4 (en) IMPROVED LARYNGOSCOPY
ZA201207862B (en) Improvements in embossing techniques
GB201012276D0 (en) Improvements in proximity detection
GB201019118D0 (en) Conjugates and their uses in molecular imaging
ZA201104161B (en) Dihydroetorphines and their preparation
IL216626A0 (en) Albumin-amyloid peptide conjugates and uses thereof
GB0906449D0 (en) Improvements in imaging
GB0914446D0 (en) Bioconjugates and their uses in imaging
GB201017835D0 (en) Nanoparticles and their uses in molecular imaging
GB201005441D0 (en) Improvements in wheelchairs
GB0900592D0 (en) Two in one-toi in one
GB201007678D0 (en) Tripeptide conjugates
GB0813185D0 (en) Improvements in actibacterial drugs

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)